Raymond James Downgrades Juno Therapeutics (JUNO) to Market Perform
Tweet
Share
E-mail
Get Alerts JUNO Hot Sheet
Price: $86.96 --0%
Rating Summary:
4 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
4 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Raymond James downgraded Juno Therapeutics (NASDAQ: JUNO) from Outperform to Market Perform and removed its price target (prior $39.00).
For an analyst ratings summary and ratings history on Juno Therapeutics click here. For more ratings news on Juno Therapeutics click here.
Shares of Juno Therapeutics closed at $20.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Sirius XM Radio (SIRI) to Neutral, 'risk-reward is balanced at prevailing levels'
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- HSBC Downgrades Anglo American Platinum Limited (AMS:SJ) (ANGPY) to Reduce
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
